Relationship between metabolic syndrome components and vascular properties in Japanese type 2 diabetic patients without cardiovascular disease or nephropathy

Diabetes Research and Clinical Practice

Volumn 75, Issue 2, 2007, Pages 200-206

  Yokoyama, H ^a   Kuramitsu, M ^a   Kanno, S ^a   Tada, J ^a   Yokota, Y ^a   Kamikawa, F ^a  

^a Jiyugaoka Medical Clinic   (Japan)

Author keywords

Albuminuria; Intima media thickness; Metabolic syndrome; Pulse wave velocity; Type 2 diabetes

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADULT; AGED; AGING; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; DIABETIC PATIENT; DIET THERAPY; DISEASE ASSOCIATION; DISEASE DURATION; ETHNIC GROUP; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; ALBUMINURIA; ATHEROSCLEROSIS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; REFERENCE VALUES; RISK FACTORS; TRIGLYCERIDES;

EID: 33845423679     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.06.015     Document Type: Article

References (30)

1. Pyorala K., Laakso M., and Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diab. Metab. Rev. 3 (1987) 463-524
2. Ferrannin E., Haffner S.M., Mitchell B.D., and Stern M.O. Hyperinsulinemia: the key feature of cardiovascular and metabolic syndrome. Diabetologia 34 (1991) 416-422
3. Isomaa B., Almgren P., and Tuomi T. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diab. Care 24 (2001) 683-689
4. Kuusisto J., Lempiainen P., and Mykkanen L. Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men. Diab. Care 24 (2001) 1629-1633
5. Bonora E., Targher G., and Formentini G. The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects prospective data from the Verona Diabetes Complication Study. Diab. Med. 21 (2003) 52-58
6. Bruno G., Merletti F., Biggeri A., Bargero G., Ferrero S., Runzo C., et al. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes. The Casale Monferrato Study. Diab. Care 27 (2004) 2689-2694
7. O'Leary D.R., Polak J.F., and Kronmal R.A. Distubution and correlates of sonographically detected carotid artery disease in the cardiovascular health study. Stroke 23 (1992) 1752-1760
8. Bots M.L., Hoes A.W., and Koudstaal P.J. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 96 (1997) 1432-1437
9. van Popele N.M., Grobbee D.E., and Bots M.L. Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke 32 (2001) 454-460
10. Yokoyama H., Aoki T., and Imahori M. Subclinical atherosclerosis is increased in type 2 diabetic patients with microalbuminuria evaluated by intima-media thickness and pulse wave. Kidney Int. 66 (2004) 448-454
11. Cruickshank K., Riste L., and Anderson S.G. Aortic pulse wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?. Circulation 106 (2002) 2085-2090
12. Yamashina A., Tomiyama H., and Arai T. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens. Res. 26 (2003) 615-622
13. Dinneen S.F., and Gerstein H.C. The association of microalbuminuria and mortality in non-insulin dependent diabetes mellitus. A systematic overview of the literature. Arch. Intern. Med. 157 (1997) 1413-1418
14. Gestein H.C., Mann J.F.E., and Yi Q. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286 (2001) 421-426
15. The Committee of Japan Diabetes Society for the Diagnostic Criteria of Diabetes mellitus, Report of the Committee of Japan Diabetes Society on the Classification and Diagnostic Criteria of Diabetes Mellitus, J. Jpn. Diab. Soc. 42 (1999) 385-404.
16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive Program of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III), JAMA 285 (2001) 2486-2497.
17. International Diabetes Federation, The IDF consensus worldwide definition of the metabolic syndrome, http://www.idf.org/(accessed 2 June 2005).
18. The Examination Committee of Criteria for Obesity Disease in Japan, Japan Society for the Study of Obesity. New criteria for 'Obesity Disease' in Japan, Circ. J. 66 (2002) 987-992.
19. Kuusisto J., Lempiainen P., and Mykkanen L. Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men. Diab. Care 24 (2001) 1629-1633
20. Wang J.J., Qiao Q., and Mittinen M.E. The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a Chinese population with high postprandial glucose. Diab. Care 27 (2004) 2429-2437
21. Salomaa V., Riley W., and Kark J.D. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC Study. Circulation 91 (1995) 1432-1443
22. Rajala U., Laakso M., and Paivansalo M. Low insulin sensitivity measured by both quantitative insulin sensitivity check index and homeostasis model assessment method as a risk factor of increased intima-media thickness of the carotid artery. J. Clin. Endocrinol. Metab. 87 (2002) 5092-5097
23. Czernichow S., Bertrais S., Oppert J.M., Galan P., Blacher J., Ducimetiere P., et al. Body composition and fat repartition in relation to structure and function of large arteries in middle-aged adults (the SU.VI.MAX study). Int. J. Obes. 29 (2005) 826-832
24. Sone H., Mizuno S., Fujii H., Yoshimura Y., Yamasaki Y., Ishibashi S., et al. Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in Asian diabetic patients?. Diab. Care 28 (2005) 1463-1471
25. Scuteri A., Najjar S.S., and Muller D.C. Metabolic syndrome ampifies the age-associated increases in vascular thickness and stiffness. J. Am. Coll. Cardiol. 43 (2004) 1388-1395
26. Deckert T., Feldt-Rasmussen B., and Borch-Johnsen K. Albuminuria reflects widespread vascular damage: the Steno Hypothesis. Diabetologia 32 (1989) 219-226
27. Jensen J.S. Renal and systemic transvascular albumin leakage in severe atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 1324-1329
28. Yokoyama H., and Deckert T. Central role of TGF-β in the pathogenesis of diabetic nephropathy and macrovascular complications: a hypothesis. Diab. Med. 13 (1996) 313-320
29. Yokoyama H., Hoyer P.E., Hansen P.M., van den Born J., Jensen T., Berden J.H.M., et al. Immunohistochemical quantification of heparan sulfate proteoglycan and collagen IV in skeletal muscle capillary basement membranes of patients with diabetic nephropathy. Diabetes 46 (1997) 1875-1880
30. Yokoyama H., Kuramitsu M., Yokota Y., Tada J., Kamikawa F., Kanno S., et al. Effect of combination therapy with pioglitazone and acarbose on the progression of early atherosclerosis in patients with type 2 diabetes. J. Jpn. Diab. Soc. 49 (2006) 197-2006